Medimix

Quick links to important sections

Medimix

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medimix

Property Description
Active Ingredient Nitrous Oxide (N2O) and Oxygen (O2)
Form Medicinal Gas
Pharmacological Class Analgesic, Anxiolytic, Sedative
Common Use Acute procedural pain and anxiety relief
Origin Synthetic (N2O), Isolated/Purified (O2)

What is Medimix and What Type of Medicine Is It?

Medimix is a prescription medicinal gas classified pharmacologically as a potent analgesic and anxiolytic, provided in a fixed 50% to 50% volumetric mixture of Nitrous Oxide and Oxygen. This drug entity is a combination product that utilizes synthetic Nitrous Oxide (N2O), an agent that induces central nervous system (CNS) depression, blended with purified medical Oxygen (O2). It is widely regarded as a member of the inhaled sedative drug class, positioning it as a weak anesthetic agent primarily used to achieve conscious sedation and relative analgesia. This specific 50%/50% formulation, available under trade names like Medimix, Entonox, or Nitronox, is clinically recognized for its ability to provide rapid symptomatic relief for patients across all age groups, particularly in emergency and procedural settings.

What is the Composition of Medimix?

The composition of Medimix consists of the active ingredient Nitrous Oxide and the essential medical carrier gas Oxygen. This formulation is presented as a compressed liquefied gas within a specialized delivery system, representing the required dosage form for inhalation administration. The critical 50%/50% fixed-ratio composition is a necessary safety feature; the half-volume of Oxygen guarantees that adequate blood oxygenation is physiologically maintained during the therapeutic effect of the Nitrous Oxide component. The inclusion of the N2O/O2 combination on the Essential Medicines List reflects its established use and efficacy in healthcare systems globally.

What is the General Purpose of Medimix?

The general purpose of Medimix is to provide immediate, reversible relief from acute pain and reduce associated anxiety during short medical procedures. The simultaneous provision of profound analgesia and a calming anxiolytic effect facilitates patient comfort and cooperation. Inhaled N2O/O2 mixtures are used for rapid pain relief in emergency and acute settings. This utility is reliant on the drug's physical properties: as an inhaled gas, it exhibits exceptionally rapid onset and an equally rapid recovery profile, which is beneficial for time-sensitive, procedural support.

Regulatory References

  1. Nitrous Oxide - StatPearls
  2. Nitrous oxide on WHO Essential Medicines List

What side effects are possible with Medimix?

Possible Side Effects and Safety Information

The safety profile of the 50% Nitrous Oxide/50% Oxygen medicinal gas is characterized by effects that typically have a rapid onset and rapid reversal following the cessation of administration. The documented adverse reactions primarily involve the central nervous system and the gastrointestinal tract, as classified in official regulatory documents.

Common and Infrequent System-Organ Effects

Side effects that are common or most common in clinical use include dizziness, drowsiness, nausea, and vomiting. Infrequently reported effects may include paresthesia (a tingling sensation in the lips or fingers), euphoria, disorientation, and dry mouth.

System-Organ Class Common/Infrequent Reactions
Nervous System Disorders Dizziness, Drowsiness, Paresthesia
Gastrointestinal Disorders Nausea, Vomiting, Dry Mouth

Serious Safety Considerations and Restrictions

Serious adverse events are rare and are largely associated with prolonged or repeated, non-procedural use. A key safety consideration is the potential for Vitamin B12 inactivation, which can lead to neurological complications (myeloneuropathy) or bone marrow suppression when exposure is chronic, but not typically with short-term procedural use.

Contraindications are explicitly documented for conditions where gas is trapped in a rigid closed space, as the mixture can increase pressure in these areas. The gas is therefore restricted in patients with conditions such as pneumothorax, bowel obstruction, or suspected air embolism.

Population-Specific Notes

The regulatory safety profile notes specific considerations for certain groups: the mixture is not intended for use in infants or neonates, and it is not recommended during the first trimester of pregnancy due to the theoretical risk associated with Vitamin B12 metabolism.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Medimix

The following section summarizes the officially documented overdose profile for the 50% Nitrous Oxide and 50% Oxygen mixture, based strictly on government regulatory documents.

Property Description
Documented overdose presentations: Overexposure is documented to cause signs of CNS depression (reduced consciousness, anesthetic effects), asphyxiation or rapid suffocation, diffusion hypoxia (following cessation), loss of laryngeal reflexes, and heart rhythm disorders (tachycardia, bradycardia).
Physiological systems affected: Central Nervous System (CNS), Respiratory System, Cardiovascular System, and Haematological System (due to B12 inactivation risk from prolonged/frequent exposure).
Emergency-response statements: Seek immediate medical treatment. Remove patient to fresh air. Give artificial respiration if not breathing. Give oxygen if breathing is difficult.
When immediate medical help is required: Immediate medical help is required for life-threatening symptoms such as acute asphyxiation, loss of consciousness, or severe breathing difficulty. Urgent contact with emergency services is mandated in such cases.

Overdose Classifications (High-Level)

Property Description
Severity classification: Overdose carries a risk of Severe to Life-Threatening outcomes, particularly acute respiratory failure and severe delayed neurological sequelae.
Overdose-context constraints: No specific antidote is known; management is strictly symptomatic and supportive. Haematological monitoring is specified as a requirement for suspected prolonged or frequent exposure.

Connection to the overall overdose profile:

Regulatory documents define the overdose profile by its primary risks: immediate, potentially fatal hypoxia and long-term neurological toxicity. The conditions for seeking emergency help are clear-cut, centered on the prompt management of respiratory or CNS depression through supportive care, including mandated oxygen supplementation and the need for urgent professional medical attention when severe manifestations occur.

Therapeutic Uses of Medimix

What Medimix Treats: Main Uses and Benefits

Medimix (the 50% Nitrous Oxide and 50% Oxygen mixture) is commonly used to provide symptomatic relief across therapeutic domains where symptoms related to systemic imbalance are present. Its primary therapeutic role is considered relevant across numerous clinical contexts. The gas mixture helps address symptom clusters that create noticeable temporary functional strain.

Quick Fact: Relief for Pain and Distress

Quick Fact: Relief for Acute Pain and Anxiety. The medication is relevant for easing symptoms related to acute procedural discomfort and associated situational distress during medical and dental interventions. It is considered relevant in situations involving acute procedural pain, situational anxiety, and specialized acute episodes like labor.

This supportive relief contributes to easing discomfort and supports general well-being during symptomatic periods. This benefit is relevant when symptoms that interfere with daily functioning are present, and may help patients cope more steadily with symptom fluctuations across conditions presenting with acute episodes where short-term symptomatic assistance is needed.

Regulatory References

  1. NIH StatPearls overview of Nitrous Oxide

Eligibility and Restrictions for Use

Medimix (50% Nitrous Oxide and 50% Oxygen) is strictly governed by population eligibility rules based on its regulatory classification. These official rules primarily address the drug's effect on gas-filled spaces and metabolic pathways.

Official Eligibility Status

Eligibility Status Applicable Population/Condition
Permitted Adults, children able to operate the self-administered equipment, and women in labor for short-term relief.
Use with Caution Patients with mild to moderate cardiac dysfunction, compromised chemoreceptor sensitivity (e.g., COPD), or those at risk of vitamin B12 deficiency.
Not Recommended Use exceeding 24 hours total or more frequently than every four days without close hematological monitoring.

Absolute Contraindications

The medicine must not be used in patients presenting with conditions where the gas may cause dangerous expansion within a closed body cavity. This includes conditions such as pneumothorax, severe bullous emphysema, air embolism, acute bowel obstruction, or following a recent intraocular gas injection. Use is further prohibited for patients with a decreased level of consciousness that prevents cooperation, increased intracranial pressure, severe cardiac failure, or a diagnosed but untreated vitamin B12 or folic acid deficiency.

What should I know about interactions with other medicines?

Official Interaction Profile

The official interaction profile for Medimix (Nitrous Oxide 50% / Oxygen 50%) is defined by two primary categories of interaction risk: pharmacodynamic and specific substance effects.

Drug-Drug Interactions

  • Additive Central Nervous System (CNS) Depression: Co-administration with centrally acting depressant medicinal products, such as opiates, benzodiazepines, and certain psychotropics, is officially linked to an additive pharmacodynamic effect. This results in an increased risk of pronounced sedation and possible compromise of protective reflexes.
  • Biochemical Potentiation Risk: The Nitrous Oxide component causes inactivation of Vitamin B12. This mechanism potentiates the effect of agents that interfere with folate metabolism, such as Methotrexate, leading to restrictions on co-use or mandating extreme caution.
  • Pulmonary Toxicity Risk: The fixed 50% Oxygen concentration is officially noted to increase the risk of pulmonary toxicity when used in conjunction with specific lung-toxic agents, including Bleomycin, Amiodarone, and Nitrofurantoin. When co-administered with these substances, use must be carried out with caution and exposure must be kept as low as possible.

Substance and Population Constraints

  • Product Safety Constraints: The regulatory labeling strictly prohibits the presence of oil or grease on the cylinder or delivery equipment. Furthermore, alcohol-based hand hygiene gels must be fully evaporated before handling the apparatus, as this constitutes an administration substance-safety constraint.
  • Population Notes: The potential for Vitamin B12 inactivation necessitates official caution when administering Medimix to patients with known or suspected deficiencies in Vitamin B12 or folic acid.

Mechanism of Action

Modulation of Microbial Biofilms and Cell Walls

This domain covers the engagement of specific herbal constituents (e.g., from Neem and Indian Barberry) with microbial systems. The mechanism involves the disruption of bacterial and fungal cell wall integrity or the inhibition of their growth pathways. This action influences the maintenance of microbial population density, which stems from the inhibition of proliferation pathways.


Regulation of Inflammatory Mediator Pathways

This mechanistic cluster focuses on the ability of ingredients like Indian Sarsaparilla and Chopchini (China Root) to modulate key pathways associated with heightened physiological responses in the skin. The active components engage mechanisms that regulate the production or action of inflammatory mediators. The pathway modulation influences the magnitude of downstream pro-inflammatory signaling, resulting in reduced mediator response.


Enzymatic and Molecular Pathway Influence on Skin Integrity

This area involves the influence of components like Licorice (Yashti) on skin processes. This mechanism initiates or suppresses signaling sequences related to cell proliferation and the structural integrity of the skin's barrier function. The influence on signaling processes contributes to the modification of epidermal cell differentiation and structural protein synthesis.

Dosage and Administration Information

How Medimix is Used: Official Administration Guidelines

Medimix, the medicinal gas consisting of a fixed 50% Nitrous Oxide and 50% Oxygen mixture, is strictly administered via inhalation. The official usage patterns are defined by a specific delivery mechanism, a fixed concentration, and acute, procedural settings.

Dosing and Administration Method

There is no fixed numerical dose for this product. Dosing is managed by the patient’s own respiratory effort, which is the sole factor controlling the flow through a demand valve delivery system. This means the gas is delivered only when the patient actively inhales through a mask or mouthpiece. This self-administered, demand-controlled method is the core principle of its official use for providing acute, short-term relief.

Procedural Timing and Duration

Administration should begin shortly before the desired analgesic effect is required for a procedure, such as a dental intervention or dressing change. Inhalation must continue throughout the painful episode, with the effects rapidly subsiding within a few minutes after cessation. While generally used for brief periods, the mixture is not indicated for continuous use exceeding 24 hours, or more frequently than every four days, without specific medical supervision and monitoring.

Key Administration Requirements

The gas mixture must be administered by adequately trained personnel in a location where emergency resuscitation equipment is immediately available. The fixed 50%/50% mixture must be administered from the cylinder at a temperature higher than −5 °C to prevent the component gases from separating, which would otherwise compromise the intended concentration. The administration is approved for use in adults and children older than 1 month.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Medimix

This section summarizes the types of high-quality research and the specific outcomes that governmental and peer-reviewed sources have focused on for this medicinal gas mixture.


Evidence for Use in Acute Procedural Pain and Anxiety Relief

Research exploring Medimix for short medical or dental interventions includes Randomized Controlled Trials (RCTs). In these studies, research explored the gas mixture against a placebo or against other types of acute pain medication. These studies were used in research exploring how symptoms change over time, where researchers examined outcomes such as those related to physical discomfort and patient-reported outcomes describing perceived discomfort.

The findings describe patterns observed in the studies over the very short duration of use. Data show patterns related to how rapidly the measured changes start and stop when the gas is administered or withdrawn. Studies also monitored whether the medical procedure was successfully completed. However, the follow-up durations were limited. Since the gas is only administered for a few minutes, long-term effects are not fully established, as outcomes reflecting daily functioning or activity level days or weeks later are not generally examined.


Evidence for Use in Analgesia During Labor

Medimix was studied for use as an analgesic intervention for pregnant women (parturients) during labor. This research mainly involved RCTs and Systematic Reviews where the gas was compared to receiving pure oxygen or to alternative pain management options, such as neuraxial analgesia. Research examined outcomes related to physical discomfort during the active phase of labor and immediate neonatal outcomes, such as Apgar scores.

Findings were mixed regarding the magnitude of pain score changes, with some analyses described the magnitude of pain score changes recorded when evaluated against other pain management methods. While studies help show what has been observed so far, evidence quality varies across studies, and systematic reviews have pointed to methodological heterogeneity (differences in how trials were performed), which can affect overall certainty.


What Research Gaps and Uncertainties Remain

A research gap is that long-term effects are not fully established, and long-term outcomes are not typically tracked because the administration is so brief. Subgroup findings are uncertain for individuals with pre-existing complex conditions, as these groups are often excluded from or underrepresented in the primary RCTs. Furthermore, comparative evidence is lacking when trying to evaluate the mixture against higher concentrations sometimes used in other countries.

Key Studies & References

  1. Nitrous Oxide Toxicity - StatPearls (NIH/NCBI)

Frequently Asked Questions (FAQ)

Common questions about Medimix (FAQ)

Q: Can Medimix be used if a person has liver problems, according to the official label?

Official documentation does not typically list liver problems or hepatic dysfunction as a specific restriction or contraindication for Medimix.

Regulatory information indicates the drug is eliminated primarily through the lungs, which means metabolism by the liver is not the main pathway.


Q: Does the time of day matter when taking Medimix?

No, the timing of Medimix administration is not based on the time of day, such as morning or evening.

Official guidance defines the timing based on the acute need for procedural pain relief, stating administration should begin shortly before the desired analgesic effect is required for a procedure.


Q: How long does Medimix stay in your system after the last dose?

Medimix is known for its rapid elimination profile. Since the gas is not metabolized by the body, it is quickly eliminated unchanged primarily through exhalation from the lungs.

Official information indicates that the drug's effects typically subside quickly, often within a few minutes after inhalation is stopped, reflecting its rapid elimination.


Q: What is the official status of Medimix use for people with kidney impairment?

Official product information does not generally list kidney impairment as a major restriction.

The lack of a specific restriction is related to the drug being excreted unchanged through the lungs, meaning the kidneys are not the primary route for elimination.


Q: What should I do if I accidentally miss a dose of Medimix?

Medimix is administered only on-demand for acute, short-duration procedures, not on a fixed, scheduled basis.

Because there is no daily schedule or set regimen, the concept of a 'missed dose' does not apply to this type of medicinal gas.


Q: Are there any common over-the-counter pain relievers that interact with Medimix?

The official interaction profile lists restrictions for central nervous system depressants (like opiates) and specific anti-cancer or lung-toxic agents.

However, common, non-narcotic over-the-counter pain relievers, such as acetaminophen or ibuprofen, are generally not listed as having specific interactions with Medimix.


Q: Do studies suggest that Medimix works better for certain age groups?

Official regulatory documents state that the gas is approved for use in both adults and children older than 1 month, indicating its general utility across these age ranges.

Regulatory summaries focus on overall effectiveness and do not typically contain specific claims of superior efficacy for one age group over another.


Q: Can I take Medimix if I am also taking vitamins or herbal supplements?

The most significant metabolic-related constraint noted in official documents is the required caution for patients with pre-existing Vitamin B12 deficiency.

Interactions with other vitamins or most common herbal supplements are generally not specifically listed in the official product information.


Q: Is it true that Medimix can cause mild dizziness?

Yes, dizziness is officially listed as a common side effect.

Official sources generally characterize common effects as those that occur frequently but are typically transient and not severe.


Q: Is there a generic version of Medimix available?

Medimix is the trade name for a fixed 50% Nitrous Oxide and 50% Oxygen gas mixture.

Since this is a standardized fixed-ratio gas, it is manufactured and sold globally under various trade names (such as Entonox or Nitronox). This means the fixed-ratio gas is a standardized formulation that may be sold under various names.


Q: What are the most commonly reported side effects in research studies on Medimix?

The most frequently reported effects listed in regulatory documents are classified as common reactions.

These common reactions include dizziness, drowsiness, nausea, and vomiting.


Q: Does Medimix have any restrictions related to driving or operating heavy machinery?

Yes, official labeling contains an advisory regarding post-administration activities.

It is officially advised that patients must not drive or operate complex machinery until full cognitive function has returned following administration.


Q: How is Medimix generally eliminated from the body?

Medimix is eliminated quickly and unchanged from the body primarily through exhalation.

The product is an inhaled gas that does not undergo metabolic change (is not broken down by the body). It is simply exhaled.


Q: What is the purpose of the inactive ingredients in the Medimix tablet/capsule?

Medimix is a medicinal gas, not a tablet or capsule. Its components are the active ingredient, Nitrous Oxide, and the carrier gas, Oxygen.

Because of its gaseous form, this product contains no inactive ingredients (excipients), which are typically found in solid dosage forms.


Q: Is Medimix physically addictive?

Official labeling typically contains a statement regarding the drug's potential for dependence or abuse.

Inhaled nitrous oxide is generally described as having a low potential for abuse or physical dependence when used as intended for acute, procedural analgesia.


Q: What is the difference between the 'active ingredient' and 'inactive ingredients' in Medimix?

The active ingredient is Nitrous Oxide, which provides the analgesic and anxiolytic effects.

The only other component is Oxygen, which is a medical carrier and safety gas. The product does not contain any traditional inactive ingredients (excipients).


Q: Does Medimix interact with any common blood pressure medications?

The official interaction profile does not typically list common blood pressure medications as having a specific drug-drug interaction with Medimix.

However, official warnings do advise caution for patients with pre-existing or severe cardiac dysfunction.


Q: Is it necessary to take Medimix with food?

No, it is not necessary to take Medimix with food.

As an inhaled medicinal gas, its administration and absorption occur through the lungs and are completely independent of food intake or the digestive system.


Q: What is the chance of experiencing a severe side effect from Medimix, based on clinical data?

Official documents classify severe adverse events, such as neurological complications from chronic use, as rare or very rare.

This classification indicates that the occurrence of these events is infrequent, based on available clinical data.


Q: Can Medimix be taken with birth control pills?

Hormonal contraceptives, such as birth control pills, are not typically listed in the official interaction profile for this gas mixture.

The regulatory profile focuses on interactions with centrally acting depressants and drugs that affect Vitamin B12 metabolism.


Q: Do I need a prescription to get Medimix?

Yes, official documents classify Medimix as a prescription medicinal gas.

This classification requires the product to be provided within a professional medical setting.


Q: What is the recommended storage temperature range for Medimix?

Storage instructions are specific to maintain the gas ratio and cylinder safety.

Cylinders must be protected from freezing (below 0 C) and must also be protected from excessive heat (e.g., above 50 C) to prevent unsafe pressure increase.


Q: Can Medimix be taken alongside acid reflux medication?

Acid reflux medications are not typically listed in the official interaction profile for this medicinal gas mixture.

The focus of regulatory interaction warnings is on CNS depressants and drugs that affect Vitamin B12 metabolism.


Q: Does Medimix contain gluten or lactose?

As a medicinal gas consisting only of Nitrous Oxide and Oxygen, Medimix does not contain any solid excipients.

Therefore, the product contains no gluten or lactose.


Q: If I have a history of allergies, is Medimix appropriate for me?

Official labeling lists known hypersensitivity or allergy to the active substance (Nitrous Oxide) as a contraindication.

Official guidelines emphasize that contraindications, including hypersensitivity, should be determined by a qualified healthcare professional.


Q: Are there any studies comparing the long-term safety profile of Medimix versus placebo?

Official regulatory documents acknowledge that the administration of Medimix is very brief, typically lasting only a few minutes.

The brief administration duration is why long-term effects are not fully established, and long-term comparative study data is generally limited.

How should Medimix be stored and disposed of?

How to Store and Dispose of Medimix?

As a compressed medicinal gas, Medimix (Nitrous Oxide/Oxygen) must be stored and handled according to specific regulatory safety requirements defined by national health authorities.

Storage Component Requirement
Temperature Protect from freezing (below 0 C) to maintain the gas ratio and protect from excessive heat (e.g., above 50 C) to prevent unsafe pressure increase.
Environment Store securely in a well-ventilated area, away from ignition sources, flames, oil, grease, and flammable materials.
Container Keep in the original gas cylinder, with the valve tightly closed when not in use. Secure the cylinder to prevent falling.
Child Safety Must be kept strictly out of the sight and reach of children in a secure location.
Disposal Return unused or expired cylinders to the supplier or an authorized medical waste handler, as disposal must follow special pharmaceutical waste protocols for pressurized containers.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Medimix found in:

A-Z Index: